Viridian Therapeutics
Shan Wu currently serves as the Chief Business Officer at Viridian Therapeutics, Inc. Previously, Shan held various positions at Magenta Therapeutics, including Vice President of Business Development and Investor Relations, Senior Director, and Director of Business Development. Additionally, experience includes serving as Associate Director of Strategic Insights & Analytics at Biogen, Manager at Clarion Healthcare, and Research Fellow at the United Nations Industrial Development Organization's China Office. Educational qualifications include a Doctor of Philosophy (Ph.D.) in Biological Engineering from the Massachusetts Institute of Technology and a Bachelor's Degree in Electrical/Computer Engineering from the University of Virginia.
This person is not in any offices
Viridian Therapeutics
2 followers
Viridian is dedicated to improving patients’ lives through the discovery and development of RNA-based therapeutics, with a specific focus on microRNAs.